BriaCell Therapeutics Financial Overview
BriaCell Therapeutics's market cap is currently C$26.64M. The company's EPS TTM is C$-6.038; its P/E ratio is -0.13; BriaCell Therapeutics is scheduled to report earnings on December 11, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
